Stay updated on Daratumumab in PGNMID and C3 GN Clinical Trial

Sign up to get notified when there's something new on the Daratumumab in PGNMID and C3 GN Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Daratumumab in PGNMID and C3 GN Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The site revision tag was updated to v3.6.5, replacing the previous v3.6.4. This indicates an internal update to the page template or backend with no changes to the study content shown.
    Difference
    0.1%
    Check dated 2026-08-11T19:27:52.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    Change Detected
    Summary
    Revision metadata updated from v3.6.3 to v3.6.4 on the page, indicating a small internal update.
    Difference
    0.1%
    Check dated 2026-07-28T13:19:20.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    No additions or deletions are present for this page in the provided data. There are no content changes to interpret.
    Difference
    0.1%
    Check dated 2026-07-21T11:40:37.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    No changes are recorded for this page; the displayed study details remain the same based on the provided data.
    Difference
    0.1%
    Check dated 2026-07-14T10:45:35.000Z thumbnail image
  6. Check
    47 days ago
    Change Detected
    Summary
    Revision: v3.6.3 was added and Revision: v3.6.0 was removed, indicating an updated version tag for the page. This reflects an administrative update to the page's revision history rather than changes to study content.
    Difference
    0.1%
    Check dated 2026-06-30T02:25:16.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    Recruitment is now listed as No longer looking for participants, indicating enrollment has ended. The page also adds new help/navigation sections (How to Read a Study Record, Common Questions, How to Join a Study) and updates the Intervention/Treatment label formatting along with a revision note to reflect documentation improvements.
    Difference
    0.5%
    Check dated 2026-06-15T20:45:16.000Z thumbnail image

Stay in the know with updates to Daratumumab in PGNMID and C3 GN Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Daratumumab in PGNMID and C3 GN Clinical Trial page.